516 related articles for article (PubMed ID: 25496992)
21. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.
Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T
Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
Kai AK; Chan LK; Lo RC; Lee JM; Wong CC; Wong JC; Ng IO
Hepatology; 2016 Aug; 64(2):473-87. PubMed ID: 27018975
[TBL] [Abstract][Full Text] [Related]
23. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
25. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells.
Wang N; Wang X; Tan HY; Li S; Tsang CM; Tsao SW; Feng Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854312
[TBL] [Abstract][Full Text] [Related]
26. A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis.
Li C; Wu X; Zhang H; Yang G; Hao M; Sheng S; Sun Y; Long J; Hu C; Sun X; Li L; Zheng J
Int J Biol Macromol; 2015 Apr; 75():115-20. PubMed ID: 25597429
[TBL] [Abstract][Full Text] [Related]
27. A polysaccharide from mushroom Huaier retards human hepatocellular carcinoma growth, angiogenesis, and metastasis in nude mice.
Zou Y; Xiong H; Xiong H; Lu T; Zhu F; Luo Z; Yuan X; Wang Y
Tumour Biol; 2015 Apr; 36(4):2929-36. PubMed ID: 25492485
[TBL] [Abstract][Full Text] [Related]
28. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
30. HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1α.
Chen P; Duan X; Li X; Li J; Ba Q; Wang H
Oncogene; 2020 Apr; 39(14):2863-2876. PubMed ID: 32034309
[TBL] [Abstract][Full Text] [Related]
31. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.
Lin D; Wu J
World J Gastroenterol; 2015 Nov; 21(42):12171-8. PubMed ID: 26576101
[TBL] [Abstract][Full Text] [Related]
33. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
Han M; Gao H; Ju P; Gao MQ; Yuan YP; Chen XH; Liu KL; Han YT; Han ZW
Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183
[TBL] [Abstract][Full Text] [Related]
34. Identification of ACTG2 functions as a promoter gene in hepatocellular carcinoma cells migration and tumor metastasis.
Wu Y; Liu ZG; Shi MQ; Yu HZ; Jiang XY; Yang AH; Fu XS; Xu Y; Yang S; Ni H; Shen SJ; Li WD
Biochem Biophys Res Commun; 2017 Sep; 491(2):537-544. PubMed ID: 28385530
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
37. HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib.
Song Z; Liu T; Chen J; Ge C; Zhao F; Zhu M; Chen T; Cui Y; Tian H; Yao M; Li J; Li H
Cancer Lett; 2019 Sep; 460():96-107. PubMed ID: 31247273
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy.
Liu YM; Xia Y; Dai W; Han HY; Dong YX; Cai J; Zeng X; Luo FY; Yang T; Li YZ; Chen J; Guan J
BMC Cancer; 2014 Nov; 14():889. PubMed ID: 25429777
[TBL] [Abstract][Full Text] [Related]
39. Columbamine suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK1/2 MAPK signaling pathways.
Lin Z; Li S; Guo P; Wang L; Zheng L; Yan Z; Chen X; Cheng Z; Yan H; Zheng C; Zhao C
Life Sci; 2019 Feb; 218():197-204. PubMed ID: 30582951
[TBL] [Abstract][Full Text] [Related]
40. Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.
Zhuang PY; Zhang JB; Zhang W; Zhu XD; Liang Y; Xu HX; Xiong YQ; Kong LQ; Wang L; Wu WZ; Tang ZY; Qin LX; Sun HC
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1891-900. PubMed ID: 20213095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]